interview_age |
VALUE_RANGE, |
VALUE_RANGE: 0 :: 1260 |
VALUE_RANGE: 0::1440 |
04/04/2024 13:54 PM
|
sex |
DESCRIPTION |
DESCRIPTION: Sex of the subject |
DESCRIPTION: Sex of subject at birth |
07/09/2021 10:38 AM
|
interview_date |
NOTES, |
NOTES: Required field |
NOTES: |
01/08/2021 10:21 AM
|
visit |
ELEMENT_SIZE, |
ELEMENT_SIZE: 50 |
ELEMENT_SIZE: 60 |
06/25/2020 10:25 AM
|
sex |
VALUE_RANGE, , NOTES, |
VALUE_RANGE: M;F
NOTES: M = Male; F = Female |
VALUE_RANGE: M;F; O; NR
NOTES: M = Male; F = Female; O=Other; NR = Not reported |
02/21/2020 13:02 PM
|
gender |
PERMANENTLY ALIASED |
gender |
sex |
04/22/2019 00:00 AM
|
gender |
DESCRIPTION |
DESCRIPTION: Sex of the subject |
DESCRIPTION: Sex of the subject |
08/22/2018 10:43 AM
|
gender |
DESCRIPTION |
DESCRIPTION: Block Brief 2000: Sex of the subject |
DESCRIPTION: Sex of the subject |
08/20/2018 10:21 AM
|
gender |
DESCRIPTION |
DESCRIPTION: Sex of the subject |
DESCRIPTION: Block Brief 2000: Sex of the subject |
08/14/2018 16:18 PM
|
visit |
NOTES, |
NOTES: Character description of each type of visit |
NOTES: |
07/18/2018 13:11 PM
|
interview_date |
DESCRIPTION |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYYY |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging/biospecimen was completed. MM/DD/YYYY |
08/28/2017 15:10 PM
|
mdis07 |
VALUE_RANGE |
VALUE_RANGE: 0.0::100 |
VALUE_RANGE: |
01/17/2017 11:16 AM
|
asap13b |
NEW_MAP_ELEMENT |
|
Added data element 'asap13b' to data structure 'meddispn01'. |
12/13/2016 15:34 PM
|
asap14b |
NEW_MAP_ELEMENT |
|
Added data element 'asap14b' to data structure 'meddispn01'. |
12/13/2016 15:34 PM
|
med_str |
NEW_DATA_ELEMENT |
|
|
12/13/2016 15:34 PM
|
med_str |
NEW_MAP_ELEMENT |
|
Added data element 'med_str' to data structure 'meddispn01'. |
12/13/2016 15:34 PM
|
week |
NEW_MAP_ELEMENT |
|
Added data element 'week' to data structure 'meddispn01'. |
12/13/2016 15:34 PM
|
mdis06 |
DESCRIPTION |
DESCRIPTION: Capsule Dose Size (Phase 1 or 2 only) |
DESCRIPTION: Capsule Dose Size |
12/13/2016 15:31 PM
|
mdis07 |
DESCRIPTION |
DESCRIPTION: Dose (Phase 3 only) |
DESCRIPTION: Medication Dose |
12/13/2016 15:31 PM
|
gender |
VALUE_RANGE, NOTES |
VALUE_RANGE: M;F; T
NOTES: M = Male; F = Female; T= Transgender |
VALUE_RANGE: M;F
NOTES: M = Male; F = Female |
05/25/2016 11:51 AM
|
gender |
DESCRIPTION |
DESCRIPTION: Gender |
DESCRIPTION: Sex of the subject |
05/25/2016 11:50 AM
|
asap13b |
VALUE_RANGE |
VALUE_RANGE: 0::220 |
VALUE_RANGE: |
11/17/2015 15:37 PM
|
asap14b |
VALUE_RANGE |
VALUE_RANGE: 0::220 |
VALUE_RANGE: |
11/17/2015 15:37 PM
|
asap14b |
VALUE_RANGE, NOTES |
VALUE_RANGE: 0::145
NOTES: RANGE: 0 TO 104 |
VALUE_RANGE: 0::220
NOTES: |
11/17/2015 15:36 PM
|
asap13b |
VALUE_RANGE |
VALUE_RANGE: 0::200 |
VALUE_RANGE: 0::220 |
11/17/2015 15:36 PM
|
asap13b |
VALUE_RANGE |
VALUE_RANGE: 0::190 |
VALUE_RANGE: 0::200 |
11/17/2015 15:34 PM
|
asap13b |
VALUE_RANGE, NOTES |
VALUE_RANGE: 1::160
NOTES: RANGE: 1 TO 160 |
VALUE_RANGE: 0::190
NOTES: |
11/17/2015 14:39 PM
|
asap14b |
VALUE_RANGE |
VALUE_RANGE: 0::104 |
VALUE_RANGE: 0::145 |
11/17/2015 13:23 PM
|
asap13b |
TYPE |
TYPE: Integer |
TYPE: Float |
11/17/2015 13:18 PM
|
asap14b |
TYPE |
TYPE: Integer |
TYPE: Float |
11/17/2015 13:18 PM
|
gender |
REQUIRED |
REQUIRED: Recommended |
REQUIRED: Required |
07/23/2015 11:32 AM
|
interview_age |
REQUIRED |
REQUIRED: Recommended |
REQUIRED: Required |
07/23/2015 11:29 AM
|
asap13b |
NEW_DATA_ELEMENT |
|
|
06/05/2015 16:56 PM
|
asap14b |
NEW_DATA_ELEMENT |
|
|
06/05/2015 16:56 PM
|
interview_date |
REQUIRED |
REQUIRED: Recommended |
REQUIRED: Required |
06/04/2015 16:35 PM
|
interview_date |
REQUIRED |
REQUIRED: Required |
REQUIRED: Recommended |
06/04/2015 16:23 PM
|
interview_date |
REQUIRED |
REQUIRED: Recommended |
REQUIRED: Required |
06/04/2015 15:13 PM
|
interview_date |
REQUIRED |
REQUIRED: Required |
REQUIRED: Recommended |
06/04/2015 14:25 PM
|
interview_date |
DESCRIPTION |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYY |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYYY |
06/02/2015 17:40 PM
|
interview_date |
DESCRIPTION |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYY |
06/02/2015 17:40 PM
|
interview_age |
VALUE_RANGE |
VALUE_RANGE: 0 :: 1200 |
VALUE_RANGE: 0 :: 1260 |
06/01/2015 14:16 PM
|
mdis05 |
NEW_MAP_ELEMENT |
|
Added data element 'mdis05' to data structure 'meddispn01'. |
05/29/2015 14:57 PM
|
mdis06 |
NEW_MAP_ELEMENT |
|
Added data element 'mdis06' to data structure 'meddispn01'. |
05/29/2015 14:57 PM
|
mdis07 |
NEW_MAP_ELEMENT |
|
Added data element 'mdis07' to data structure 'meddispn01'. |
05/29/2015 14:57 PM
|
mdis05 |
NEW_DATA_ELEMENT |
|
|
05/29/2015 14:53 PM
|
mdis05 |
NEW_MAP_ELEMENT |
|
Added data element 'mdis05' to data structure 'meddispens01'. |
05/29/2015 14:53 PM
|
mdis06 |
NEW_DATA_ELEMENT |
|
|
05/29/2015 14:53 PM
|
mdis06 |
NEW_MAP_ELEMENT |
|
Added data element 'mdis06' to data structure 'meddispens01'. |
05/29/2015 14:53 PM
|
mdis07 |
NEW_DATA_ELEMENT |
|
|
05/29/2015 14:53 PM
|
mdis07 |
NEW_MAP_ELEMENT |
|
Added data element 'mdis07' to data structure 'meddispens01'. |
05/29/2015 14:53 PM
|
phase_ct |
VALUE_RANGE |
VALUE_RANGE: Pre-Rand; Phase 1/1A; Phase 2; Phase 3; Phase 4; Phase 1B; Open-Choice Phase |
VALUE_RANGE: Pre-Rand; Phase 1/1A; Phase 2; Phase 3; Phase 4; Phase 1B; Open-Choice Phase; Screening; Phase 1 |
05/28/2015 18:32 PM
|
phase_ct |
VALUE_RANGE |
VALUE_RANGE: Pre-Rand; Phase 1/1A; Phase 2; Phase 3; Phase 4; Phase 1B |
VALUE_RANGE: Pre-Rand; Phase 1/1A; Phase 2; Phase 3; Phase 4; Phase 1B; Open-Choice Phase |
05/28/2015 12:11 PM
|
week |
NOTES |
NOTES: |
NOTES: 99=week 10-week 14 |
05/19/2015 18:30 PM
|
interview_date |
REQUIRED |
REQUIRED: Recommended |
REQUIRED: Required |
03/26/2015 12:22 PM
|
phase_ct |
DESCRIPTION |
DESCRIPTION: Current Phase. Phase patient was in at the time of the assessment Phase 4 refers to the follow-up phase.
|
DESCRIPTION: Current Phase. Phase patient was in at the time of the assessment Phase 4 refers to the follow-up phase. |
01/13/2015 17:38 PM
|
src_subject_id |
DESCRIPTION |
DESCRIPTION: The site or study's subject identification |
DESCRIPTION: Subject ID how it's defined in lab/project |
01/12/2015 18:22 PM
|
week |
DESCRIPTION |
DESCRIPTION: Week in level |
DESCRIPTION: Week in level/study |
01/05/2015 11:19 AM
|
gender |
VALUE_RANGE, NOTES |
VALUE_RANGE: M;F
NOTES: M = Male; F = Female |
VALUE_RANGE: M;F; T
NOTES: M = Male; F = Female; T= Transgender |
12/01/2014 12:34 PM
|